Exonate will be present again at this year’s ARVO in Honolulu. Prof David Bates will be progressing key meetings with business development contacts. Exonate’s poster session runs from 8.15 – 10.00 on Sunday 29th April in exhibit hall 15, poster board number C0031: A novel approach to inhibit pro-angiogenic VEGF splicing in retinal vascular diseases with topical administration of small molecules optimised for retinal pharmacokinetics.
David is available for meetings whilst there and contact can be made via Louise Shave Louise.shave@exonate.com